NEWS SUMMARY: ENDESA. Markets maintain strong August performance Last week, stock markets closed with gains, with Chinese markets (CSI 300) and the FTSE 100 standing out. This performance was spurred at the end of the week by Powell’s comments in Jackson Hole in favour of rate cuts, admitting that the current, still restrictive monetary policy could be relaxed in view of the deteriorating job market. In the STOXX 600, the sectors that rose the most were defensive ones like Pharma, Utilities and...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ENDESA. EUROPA: ESSILORLUXOTTICA. Las bolsas mantienen el buen performance de agosto La semana pasada las bolsas cerraron con avances, destacando sobre todo los de la bolsa china (CSI 300) y el FTSE 100. Los índices se animaron hacia final de la semana tras unos comentarios a favor de recortes de tipos por parte de J. Powell en Jackson Hole al reconocer que la actual política monetaria todavía restrictiva podría relajarse ante el deterioro del merca...
NEWS SUMMARY: FCC. Markets kick off second half of August with drops Although no definitive peace agreement was expected to come from the talks between the US and the Ukraine-Europe delegation, stock markets took the opportunity for profit taking while rewarding defence companies in view of the possible “security guarantee” the US would offer Ukraine. In the STOXX 600, the sectors falling the most were Basic Materials and Autos, with Pharma (driven by Novo Nordisk) and Media rising the most. On...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: FCC Las bolsas empiezan la segunda quincena con caídas Aunque no se esperaba un acuerdo definitivo de Paz en las conversaciones entre EE.UU. y la delegación ucraniana-europea las bolsas aprovecharon para recoger beneficios mientras que premiaba a las empresas de defensa ante la posible “garantía de seguridad” que ofrecería Estados Unidos a Ucrania. En el STOXX 600 los sectores que más cayeron fueron R. Básicos y Autos frente a Farma (impulsada por N...
2Q'25 vs. 2Q'24 Results Sales: € 2.375 Bn (+15.8% vs. +18.1% BS(e)); EBITDA: € 350.9 M (+38.7% vs. +43.4% BS(e)); 1H'25 vs. 1H'24 Results Sales: € 4.557 Bn (+7.5% vs. +8.7% BS(e)); EBITDA: € 675.3 M (+11.0% vs. +13.0% BS(e)); EBIT: € 254.5 M (-28.3% vs. +2.6% BS(e)); Net Profit: € 80.7 M (-71.1% vs. -52.0% BS(e));
Rdos. 2T'25 vs 2T'24: Ventas: 2.375 M euros (+15,8% vs +18,1% BS(e)); EBITDA: 350,9 M euros (+38,7% vs +43,4% BS(e)); Rdos. 1S'25 vs 1S'24: Ventas: 4.557 M euros (+7,5% vs +8,7% BS(e)); EBITDA: 675,3 M euros (+11,0% vs +13,0% BS(e)); EBIT: 254,5 M euros (-28,3% vs +2,6% BS(e)); BDI: 80,7 M euros (-71,1% vs -52,0% BS(e)).
2Q'25 vs. 2Q'24 Results EBITDA: € 1.28 Bn (-4.0% vs. -5.2% BS(e) and -2.4% consensus); Net Profit: € 458.0 M (-9.8% vs. -12.8% BS(e) and -7.5% consensus); 1H'25 vs. 1H'24 Results EBITDA: € 2.711 Bn (+12.3% vs. +11.7% BS(e) and +13.3% consensus); Net Profit: € 1.041 Bn (+30.1% vs. +27.6% BS(e) and +31.0% consensus);
Rdos. 2T'25 vs 2T'24: EBITDA: 1.280 M euros (-4,0% vs -5,2% BS(e) y -2,4% consenso); BDI: 458,0 M euros (-9,8% vs -12,8% BS(e) y -7,5% consenso); Rdos. 1S'25 vs 1S'24: EBITDA: 2.711 M euros (+12,3% vs +11,7% BS(e) y +13,3% consenso); BDI: 1.041 M euros (+30,1% vs +27,6% BS(e) y +31,0% consenso);
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.